WASHINGTON (Reuters) – Novartis unit Sandoz has agreed to pay $195 million to reach a deferred prosecution agreement aimed at resolving antitrust charges, the Justice Department said on Monday.
(Reporting by Diane Bartz; Editing by Chris Reese)
Novartis unit Sandoz agrees to pay $195 million to resolve antitrust charges
